Persistent Systems has announced the launch of a new generative molecules and virtual screening solution powered by artificial intelligence. Developed in collaboration with NVIDIA, the solution leverages advanced technology stacks to transform the life sciences landscape. The project aims to significantly accelerate digital engineering processes and drug discovery through the strategic application of generative AI. By integrating NVIDIA's specialized AI hardware and software, Persistent Systems provides researchers with faster and more efficient molecular screening tools. This strategic move is expected to strengthen the company's position in the high-growth digital engineering and healthcare sectors. Investors view this partnership as a positive development that underscores Persistent Systems' commitment to innovation in the AI domain.
Sign up free to access this content
Create Free Account